Funding

Inocras

United States · Biotech · Healthtech

Whole-genome sequencing and bioinformatics platform for precision oncology

Visit inocras.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$31MAimed Bio — Role not disclosedDSC Investment — Role not disclosedDT&Investment — Role not disclosedDunamu & Partners — Role not disclosedIMM Investment — Role not disclosedInterVest — Role not disclosedKorea Investment & Securities — Role not disclosedLoftyRock Investment — Role not disclosedNDS Corporation — Role not disclosedShinhan Securities — Role not disclosedWoori Investment & Securities — Role not disclosed

Investors

Aimed BioSeries BDSC InvestmentSeries BDT&InvestmentSeries BDunamu & PartnersSeries BIMM InvestmentSeries BInterVestSeries BKorea Investment & SecuritiesSeries BLoftyRock InvestmentSeries BNDS CorporationSeries BShinhan SecuritiesSeries BWoori Investment & SecuritiesSeries B

Coverage

Aug 3, 2026Inocras · Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesinocras.com ↗